Bausch Health Companies (BHC) Net Cash Flow (2009 - 2026)

Bausch Health Companies has disclosed Net Cash Flow across 18 years of filings, most recently posting $528.0 million for Q2 2026.

• In Q2 2026, Net Cash Flow fell 3.47% year-over-year to $528.0 million; the TTM figure through Jun 2026 stood at $100.0 million (down 90.76% YoY), while the FY2025 annual figure was $63.0 million, down 77.09% from the prior year.
• Net Cash Flow came in at $528.0 million for Q2 2026 at Bausch Health Companies, up from -$9.0 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $547.0 million in Q2 2025 to a low of -$1.4 billion in Q3 2022.
• Average Net Cash Flow over 5 years is -$15.9 million, with a median of $23.5 million recorded in 2023.
• Year-over-year, Net Cash Flow slumped 26940.0% in 2022 and surged 544.72% in 2025.
• Over 5 years, Net Cash Flow stood at $63.0 million in 2022, then surged by 158.73% to $163.0 million in 2023, then surged by 198.16% to $486.0 million in 2024, then tumbled by 104.53% to -$22.0 million in 2025, then surged by 2500.0% to $528.0 million in 2026.
• Per Business Quant data, the three most recent Net Cash Flow figures were $528.0 million in Q2 2026, -$9.0 million in Q1 2026, and -$22.0 million in Q4 2025.